Biosensors for prostate cancer detection. Akbari Nakhjavani, S., Tokyay, B. K, Soylemez, C., Sarabi, M. R, Yetisen, A. K, & Tasoglu, S. Trends Biotechnol., 41(10):1248–1267, October, 2023.
Paper doi abstract bibtex Prostate cancer (PC) is one of the most common tumors and a leading cause of mortality among men, resulting in ~375 000 deaths annually worldwide. Various analytical methods have been designed for quantitative and rapid detection of PC biomarkers. Electrochemical (EC), optical, and magnetic biosensors have been developed to detect tumor biomarkers in clinical and point-of-care (POC) settings. Although POC biosensors have shown potential for detection of PC biomarkers, some limitations, such as the sample preparation, should be considered. To tackle such shortcomings, new technologies have been utilized for development of more practical biosensors. Here, biosensing platforms for the detection of PC biomarkers such as immunosensors, aptasensors, genosensors, paper-based devices, microfluidic systems, and multiplex high-throughput platforms, are discussed.
@article{akbari_nakhjavani_biosensors_2023,
title = {Biosensors for prostate cancer detection},
volume = {41},
issn = {0167-7799},
url = {http://dx.doi.org/10.1016/j.tibtech.2023.04.001},
doi = {10.1016/j.tibtech.2023.04.001},
abstract = {Prostate cancer (PC) is one of the most common tumors and a leading cause
of mortality among men, resulting in {\textasciitilde}375 000 deaths annually worldwide.
Various analytical methods have been designed for quantitative and rapid
detection of PC biomarkers. Electrochemical (EC), optical, and magnetic
biosensors have been developed to detect tumor biomarkers in clinical and
point-of-care (POC) settings. Although POC biosensors have shown potential
for detection of PC biomarkers, some limitations, such as the sample
preparation, should be considered. To tackle such shortcomings, new
technologies have been utilized for development of more practical
biosensors. Here, biosensing platforms for the detection of PC biomarkers
such as immunosensors, aptasensors, genosensors, paper-based devices,
microfluidic systems, and multiplex high-throughput platforms, are
discussed.},
number = {10},
journal = {Trends Biotechnol.},
author = {Akbari Nakhjavani, Sattar and Tokyay, Begum K and Soylemez, Cansu and Sarabi, Misagh R and Yetisen, Ali K and Tasoglu, Savas},
month = oct,
year = {2023},
keywords = {biomarkers, biosensors, healthcare, point of care, prostate cancer, Savas Scholar},
pages = {1248--1267},
}
Downloads: 0
{"_id":"4uSXnpnwLGKPHXjF6","bibbaseid":"akbarinakhjavani-tokyay-soylemez-sarabi-yetisen-tasoglu-biosensorsforprostatecancerdetection-2023","author_short":["Akbari Nakhjavani, S.","Tokyay, B. K","Soylemez, C.","Sarabi, M. R","Yetisen, A. K","Tasoglu, S."],"bibdata":{"bibtype":"article","type":"article","title":"Biosensors for prostate cancer detection","volume":"41","issn":"0167-7799","url":"http://dx.doi.org/10.1016/j.tibtech.2023.04.001","doi":"10.1016/j.tibtech.2023.04.001","abstract":"Prostate cancer (PC) is one of the most common tumors and a leading cause of mortality among men, resulting in ~375 000 deaths annually worldwide. Various analytical methods have been designed for quantitative and rapid detection of PC biomarkers. Electrochemical (EC), optical, and magnetic biosensors have been developed to detect tumor biomarkers in clinical and point-of-care (POC) settings. Although POC biosensors have shown potential for detection of PC biomarkers, some limitations, such as the sample preparation, should be considered. To tackle such shortcomings, new technologies have been utilized for development of more practical biosensors. Here, biosensing platforms for the detection of PC biomarkers such as immunosensors, aptasensors, genosensors, paper-based devices, microfluidic systems, and multiplex high-throughput platforms, are discussed.","number":"10","journal":"Trends Biotechnol.","author":[{"propositions":[],"lastnames":["Akbari","Nakhjavani"],"firstnames":["Sattar"],"suffixes":[]},{"propositions":[],"lastnames":["Tokyay"],"firstnames":["Begum","K"],"suffixes":[]},{"propositions":[],"lastnames":["Soylemez"],"firstnames":["Cansu"],"suffixes":[]},{"propositions":[],"lastnames":["Sarabi"],"firstnames":["Misagh","R"],"suffixes":[]},{"propositions":[],"lastnames":["Yetisen"],"firstnames":["Ali","K"],"suffixes":[]},{"propositions":[],"lastnames":["Tasoglu"],"firstnames":["Savas"],"suffixes":[]}],"month":"October","year":"2023","keywords":"biomarkers, biosensors, healthcare, point of care, prostate cancer, Savas Scholar","pages":"1248–1267","bibtex":"@article{akbari_nakhjavani_biosensors_2023,\n\ttitle = {Biosensors for prostate cancer detection},\n\tvolume = {41},\n\tissn = {0167-7799},\n\turl = {http://dx.doi.org/10.1016/j.tibtech.2023.04.001},\n\tdoi = {10.1016/j.tibtech.2023.04.001},\n\tabstract = {Prostate cancer (PC) is one of the most common tumors and a leading cause\nof mortality among men, resulting in {\\textasciitilde}375 000 deaths annually worldwide.\nVarious analytical methods have been designed for quantitative and rapid\ndetection of PC biomarkers. Electrochemical (EC), optical, and magnetic\nbiosensors have been developed to detect tumor biomarkers in clinical and\npoint-of-care (POC) settings. Although POC biosensors have shown potential\nfor detection of PC biomarkers, some limitations, such as the sample\npreparation, should be considered. To tackle such shortcomings, new\ntechnologies have been utilized for development of more practical\nbiosensors. Here, biosensing platforms for the detection of PC biomarkers\nsuch as immunosensors, aptasensors, genosensors, paper-based devices,\nmicrofluidic systems, and multiplex high-throughput platforms, are\ndiscussed.},\n\tnumber = {10},\n\tjournal = {Trends Biotechnol.},\n\tauthor = {Akbari Nakhjavani, Sattar and Tokyay, Begum K and Soylemez, Cansu and Sarabi, Misagh R and Yetisen, Ali K and Tasoglu, Savas},\n\tmonth = oct,\n\tyear = {2023},\n\tkeywords = {biomarkers, biosensors, healthcare, point of care, prostate cancer, Savas Scholar},\n\tpages = {1248--1267},\n}\n\n","author_short":["Akbari Nakhjavani, S.","Tokyay, B. K","Soylemez, C.","Sarabi, M. R","Yetisen, A. K","Tasoglu, S."],"key":"akbari_nakhjavani_biosensors_2023","id":"akbari_nakhjavani_biosensors_2023","bibbaseid":"akbarinakhjavani-tokyay-soylemez-sarabi-yetisen-tasoglu-biosensorsforprostatecancerdetection-2023","role":"author","urls":{"Paper":"http://dx.doi.org/10.1016/j.tibtech.2023.04.001"},"keyword":["biomarkers","biosensors","healthcare","point of care","prostate cancer","Savas Scholar"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/tdeNjdGRvEjCj6poY/Paperpile - Savas Scholar - Sep 29_9_55.bib","dataSources":["o4FjzKmMLbNsJeCiA","rpTabu3QjqyjXfwJx","ug28hqM3LvcrR5ooy","WNeEW7TRQofgFJWZF","e4sXQAiZBnJpitypW","ju36gB4zmmNQMHn4H","z3Bax9WQP5R35XnHo"],"keywords":["biomarkers","biosensors","healthcare","point of care","prostate cancer","savas scholar"],"search_terms":["biosensors","prostate","cancer","detection","akbari nakhjavani","tokyay","soylemez","sarabi","yetisen","tasoglu"],"title":"Biosensors for prostate cancer detection","year":2023}